Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds

被引:14
|
作者
Rafael, Diana [1 ,2 ,3 ]
Guerrero, Marcelo [4 ,5 ]
Marican, Adolfo [4 ,5 ,6 ]
Arango, Diego [7 ,8 ]
Sarmento, Bruno [9 ]
Ferrer, Roser [10 ]
Duran-Lara, Esteban F. [4 ,5 ]
Clark, Simon J. [11 ,12 ,13 ]
Schwartz, Simo, Jr. [1 ,10 ]
机构
[1] Univ Autonoma Barcelona UAB, Vall Hebron Inst Recerca VHIR, Drug Delivery & Targeting, Barcelona 08035, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Madrid 28029, Spain
[3] Univ Autonoma Barcelona UAB, Vall Hebron Inst Recerca VHIR, Funct Validat & Preclin Res FVPR, 20 ICTS Nanbiosis, Barcelona 08035, Spain
[4] Univ Talca, Fac Ciencias Salud, Dept Microbiol, Drug Delivery & Controlled Release,Bio & Nano Mat, Talca 3460000, Chile
[5] Univ Talca, Ctr Nanomed Diagnost & Drug Dev ND3, Talca 3460000, Chile
[6] Univ Talca, Inst Quim Recursos Nat, Talca 3460000, Chile
[7] Univ Autonoma Barcelona, Vall Hebron Univ Hosp Res Inst VHIR, Grp Biomed Res Digest Tract Tumors, Barcelona 08035, Spain
[8] Biomed Res Inst Lleida IRBLleida, Grp Mol Oncol, Lleida 25198, Spain
[9] Saude Univ Porto, i3S Inst Invest & Inovacao, Rua Alfredo Allen 208, P-4200135 Porto, Portugal
[10] Vall Hebron Hosp, Clin Biochem Grp, Barcelona 08035, Spain
[11] Eberhard Karls Univ Tubingen, Univ Eye Clin, Dept Ophthalmol, D-72076 Tubingen, Germany
[12] Eberhard Karls Univ Tubingen, Inst Ophthalm Res, D-72076 Tubingen, Germany
[13] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Fac Biol Med & Hlth, Manchester M13 9PL, England
关键词
hydrogels; stimuli-responsive; thermo-responsive; retinopathies; delivery systems; intravitreal delivery; ENDOTHELIAL GROWTH-FACTOR; DIABETIC MACULAR EDEMA; DIELS-ALDER HYDROGELS; REVERSE THERMAL GEL; DRUG-DELIVERY; INTRAOCULAR PHARMACOKINETICS; THERMORESPONSIVE HYDROGELS; POSTERIOR SEGMENT; EXTENDED-RELEASE; PROTEIN RELEASE;
D O I
10.3390/pharmaceutics15051484
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Slow-release delivery systems are needed to ensure long-term sustained treatments for retinal diseases such as age-related macular degeneration and diabetic retinopathy, which are currently treated with anti-angiogenic agents that require frequent intraocular injections. These can cause serious co-morbidities for the patients and are far from providing the adequate drug/protein release rates and required pharmacokinetics to sustain prolonged efficacy. This review focuses on the use of hydrogels, particularly on temperature-responsive hydrogels as delivery vehicles for the intravitreal injection of retinal therapies, their advantages and disadvantages for intraocular administration, and the current advances in their use to treat retinal diseases.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics
    Yun-Yi Cong
    Bin Fan
    Zi-Yuan Zhang
    Guang-Yu Li
    International Ophthalmology, 2023, 43 : 2575 - 2588
  • [2] Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics
    Cong, Yun-Yi
    Fan, Bin
    Zhang, Zi-Yuan
    Li, Guang-Yu
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (07) : 2575 - 2588
  • [3] Sustained-release drug delivery systems
    Williams, Rachel
    Cauldbeck, Helen
    Kearns, Victoria
    EYE, 2025, 39 (04) : 658 - 666
  • [4] RADIATION CROSS-LINKED HYDROGELS AS SUSTAINED-RELEASE DRUG DELIVERY SYSTEMS
    PEKALA, W
    ROSIAK, J
    RUCINSKARYBUS, A
    BUROZAK, K
    GALANT, S
    CZOLCZYNSKA, T
    RADIATION PHYSICS AND CHEMISTRY, 1986, 27 (04): : 275 - 285
  • [5] KINETICS OF SUSTAINED-RELEASE DELIVERY SYSTEMS
    DEGHENGHI, R
    GNRH ANALOGUES IN CANCER AND HUMAN REPRODUCTION, VOL 1: BASIC ASPECTS, 1989, : 137 - 141
  • [6] INTRAVITREAL SUSTAINED-RELEASE GANCICLOVIR
    SMITH, TJ
    PEARSON, PA
    BLANDFORD, DL
    BROWN, JD
    GOINS, KA
    HOLLINS, JL
    SCHMEISSER, ET
    GLAVINOS, P
    BALDWIN, LB
    ASHTON, P
    ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (02) : 255 - 258
  • [7] OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
    Chin, Eric K.
    Almeida, David R. P.
    Velez, Gabriel
    Xu, Kunyong
    Peraire, Maria
    Corbella, Maria
    Elshatory, Yasser M.
    Kwon, Young H.
    Gehrs, Karen M.
    Boldt, H. Culver
    Sohn, Elliott H.
    Russell, Stephen R.
    Folk, James C.
    Mahajan, Vinit B.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (07): : 1345 - 1351
  • [8] POLYACRYLAMIDE HYDROGELS AS SUSTAINED-RELEASE DRUG DELIVERY DRESSING MATERIALS
    ROSIAK, J
    BURCZAK, K
    PEKALA, W
    RADIATION PHYSICS AND CHEMISTRY, 1983, 22 (3-5): : 907 - 915
  • [9] Sustained-Release Silk Biomaterials for Drug Delivery and Tissue Engineering Scaffolds
    Pritchard, Eleanor M.
    Wilz, Andrew
    Li, Tianfu
    Lan, Jing-Quan
    Boison, Detlev
    Kaplan, David L.
    2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 2009, : 282 - +
  • [10] Sustained-release drug delivery systems for the treatment of glaucoma
    Kesav, Natasha P.
    Young, Cara E. Capitena
    Ertel, Monica K.
    Seibold, Leonard K.
    Kahook, Malik Y.
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (01) : 148 - 159